These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25697382)

  • 1. Prognostic Significance of Peri-procedural Myocardial Infarction in the Era of High Sensitivity Troponin: A Validation of the Joint ACCF/AHA/ESC/WHF Universal Definition of Type 4a Myocardial Infarction with High Sensitivity Troponin T.
    Liou K; Jepson N; Kellar P; Ng B; Isbister J; Giles R; Friedman D; Allan R; Lau A; Pitney M; Ooi SY
    Heart Lung Circ; 2015 Jul; 24(7):673-81. PubMed ID: 25697382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and determinants of myocardial infarction following percutaneous coronary interventions according to the revised Joint Task Force definition of troponin T elevation.
    Alcock RF; Roy P; Adorini K; Lau GT; Kritharides L; Lowe HC; Brieger DB; Freedman SB
    Int J Cardiol; 2010 Apr; 140(1):66-72. PubMed ID: 19131135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.
    Vranckx P; Farooq V; Garg S; Van Es GA; Silber S; Windecker S; Stone GW; Serruys PW
    Heart; 2012 Oct; 98(19):1424-30. PubMed ID: 22821273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varying definitions for periprocedural myocardial infarction alter event rates and prognostic implications.
    Idris H; Lo S; Shugman IM; Saad Y; Hopkins AP; Mussap C; Leung D; Thomas L; Juergens CP; French JK
    J Am Heart Assoc; 2014 Oct; 3(6):e001086. PubMed ID: 25359403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Impact of Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Interventions.
    Koskinas KC; Ndrepepa G; Räber L; Karagiannis A; Kufner S; Zanchin T; Hieber J; Hunziker L; Mayer K; Byrne RA; Heg D; Windecker S; Kastrati A
    Circ Cardiovasc Interv; 2018 Dec; 11(12):e006752. PubMed ID: 30545257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of troponin to diagnose periprocedural myocardial infarction: effect on composite endpoints in the British Bifurcation Coronary Study (BBC ONE).
    Cockburn J; Behan M; de Belder A; Clayton T; Stables R; Oldroyd K; Curzen N; Hildick-Smith D
    Heart; 2012 Oct; 98(19):1431-5. PubMed ID: 22851684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of myocardial infarction using the new universal definition: is it enough for risk stratification and guiding decision for revascularization?
    Calé R; Ferreira J; Aguiar C; Santos N; Carmo P; Figueira J; Raposo L; Gonçalves P; Silva JA
    Acute Card Care; 2010 Dec; 12(4):130-7. PubMed ID: 20954791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention.
    Sattler KJ; Herrmann J; Yün S; Lehmann N; Wang Z; Heusch G; Sack S; Erbel R; Levkau B
    Eur Heart J; 2009 Aug; 30(15):1894-902. PubMed ID: 19474052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention.
    Lim CC; van Gaal WJ; Testa L; Cuculi F; Arnold JR; Karamitsos T; Francis JM; Petersen SE; Digby JE; Westaby S; Antoniades C; Kharbanda RK; Burrell LM; Neubauer S; Banning AP
    J Am Coll Cardiol; 2011 Feb; 57(6):653-61. PubMed ID: 21292125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of Neutrophil to Lymphocyte Ratio With Periprocedural Myocardial Damage in Patients Undergoing Elective Percutaneous Coronary Intervention.
    Bressi E; Mangiacapra F; Ricottini E; Cavallari I; Colaiori I; Di Gioia G; Creta A; Di Sciascio G
    Am J Cardiol; 2016 Oct; 118(7):980-4. PubMed ID: 27515894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification of periprocedural myocardial infarction after percutaneous coronary intervention: Analysis based on the SCAI definition.
    Zhang D; Li Y; Yin D; He Y; Chen C; Song C; Yan R; Zhu C; Xu B; Dou K
    Catheter Cardiovasc Interv; 2017 Mar; 89(S1):534-540. PubMed ID: 28191726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serial high sensitivity troponin T with onset of atrial fibrillation in ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
    Gal P; Parlak E; Schellings DA; Beukema R; ten Berg J; Adiyaman A; van 't Hof AW; Elvan A
    Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):33-42. PubMed ID: 25694509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart-type fatty acid-binding protein (H-FABP) and highly sensitive troponin T (hsTnT) as markers of myocardial injury and cardiovascular events in elective percutaneous coronary intervention (PCI).
    Connolly M; Shand J; Kinnin M; Menown I; Kurth MJ; Lamont J; Mc Eneaney D
    QJM; 2018 Jan; 111(1):33-38. PubMed ID: 29040663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rise of serum troponin levels following uncomplicated elective percutaneous coronary interventions in patients without clinical and procedural signs suggestive of myocardial necrosis.
    Buturak A; Degirmencioglu A; Surgit O; Demir AR; Karakurt H; Erturk M; Yazıcı S; Serteser M; Norgaz T; Gorgulu S
    Postepy Kardiol Interwencyjnej; 2016; 12(1):41-8. PubMed ID: 26966448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periprocedural myocardial infarction during percutaneous coronary intervention in an academic tertiary centre in Johannesburg.
    Tsabedze N; McCutcheon K; Mkhwanazi L; Garda R; Vachiat A; Ramjee R; Moosa J; Maluleke T; Mukeshimana G; Karolia S; Mpanya D; Manga P
    Int J Cardiol; 2017 Mar; 230():175-180. PubMed ID: 28062147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of polyunsaturated fatty acids on periprocedural myocardial infarction after elective percutaneous coronary intervention.
    Suzuki A; Ando H; Takashima H; Kumagai S; Kurita A; Waseda K; Suzuki Y; Mizuno T; Harada K; Uetani T; Takahashi H; Yoshikawa D; Ishii H; Murohara T; Amano T
    EuroIntervention; 2014 Nov; 10(7):792-8. PubMed ID: 25415148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of High-Sensitivity Cardiac Troponin Elevation in Relation to Diagnostic Invasive Intravascular Imaging for the Assessment of Coronary Artery Disease.
    Sanuki Y; Sonoda S; Muraoka Y; Inoue K; Setoyama K; Miura T; Shimizu A; Anai R; Miyamoto T; Oginosawa Y; Tsuda Y; Araki M; Otsuji Y
    Int Heart J; 2019 May; 60(3):601-607. PubMed ID: 31105151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of patients at higher risk for myocardial injury following elective coronary artery intervention.
    Abu Sharar H; Helfert S; Vafaie M; Pleger ST; Chorianopoulos E; Bekeredjian R; Katus HA; Giannitsis E
    Catheter Cardiovasc Interv; 2020 Sep; 96(3):578-585. PubMed ID: 31638330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of spontaneous myocardial infarction and various definitions of periprocedural myocardial infarction in patients who underwent percutaneous coronary intervention.
    Liu Y; Wang W; Song J; Zhang K; Wang K; Shao C; Li P; Xu B; Yang M; Chen J; Zheng J; Tang YD
    Int J Cardiol; 2021 Jun; 333():60-68. PubMed ID: 33744346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of postpercutaneous coronary intervention myocardial infarction: insights from intravascular imaging, coronary flow, and biomarker evaluation.
    Hoole SP; Hernández-Sánchez J; Brown AJ; Giblett JP; Bennett MR; West NEJ
    Coron Artery Dis; 2018 May; 29(3):246-253. PubMed ID: 29112510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.